Building an AI-first organization requires more than adding a few tools to existing workflows. And so, Kailin Noivo sits down with Adam Pivko, CMO at Direct Meds, to explore how the company is building its own proprietary AI infrastructure, including an internal system called Flux, to connect data and deploy agents across marketing, operations, and patient experience without giving up control.

Adam explains why marketing leaders should become some of the heaviest AI users inside the business. From compressing campaign timelines to connecting full-funnel performance data, he shares how AI can help teams chase small, continuous improvements rather than waiting for one breakthrough campaign. He also discusses why successful adoption requires people who can translate business problems into AI solutions and help teams move from simply experimenting with AI to relying on it every day.

This conversation also gets into the harder questions around AI in healthcare, including HIPAA, PHI, privacy, and the tradeoff between personalization and compliance.

Adam Pivko is the Chief Marketing Officer at Direct Meds, where he is responsible for new customer acquisition channels, partnerships, technology, and creative execution. He is also the Co-Founder and Chief Strategy Officer of Autumn DNA, a health-focused company centered on personalized insights from genetics and lifestyle data. Previously, Adam served as CMO of Tierra Agency and Vice President of Strategic Partnerships at DFO Global Performance Commerce. His work sits at the intersection of growth, performance marketing, technology, and AI, with a particular focus on using data and automation to improve customer acquisition and business performance.


What you will learn:

Want to uncover hidden friction and convert more revenue? Click https://go.fame.so/0kE4Z2hR to book a demo of Noibu — the ecommerce monitoring and experience analytics platform.